In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response

被引:29
作者
Izembart, A
Aguado, E
Gauthier, O
Aubert, D
Moullier, P
Ferry, N [1 ]
机构
[1] CHU Hotel Dieu, Lab Therapie Gen, F-44035 Nantes, France
[2] Ecole Natl Vet Nantes, Serv Chirurg, F-44037 Nantes, France
关键词
D O I
10.1089/10430349950016339
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Gene transfer in regenerating dog liver using high-titer recombinant retroviral vectors carrying the E. coli beta-galactosidase gene was studied, Supernatants containing amphotropic or gibbon ape pseudotyped recombinant retroviruses were infused into a peripheral vein in beagle dogs after partial hepatectomy. The kinetics of liver regeneration were determined in the animals and daily infusions were carried out for 4 or 5 days during the regeneration period. Up to 2.8% of hepatocytes were beta-galactosidase positive at the end of the procedure. However, the number of positive cells declined rapidly and few positive hepatocytes were detected after 3 weeks, PCR demonstrated the disappearance of the provirus, Histologically, inflammatory lesions were observed in the transduced livers, Finally, we demonstrated the presence of a cytotoxic T lymphocyte immune response directed against beta-galactosidase-expressing cells, which could explain the disappearance of the transgene, This work suggests that the efficiency of in vivo gene delivery using high-titer retroviral vectors directly infused into the circulation may be hampered by a cytotoxic immune response against the infected cells.
引用
收藏
页码:2917 / 2925
页数:9
相关论文
共 28 条
[1]  
BARR D, 1995, GENE THER, V2, P151
[2]   Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes [J].
Bosch, A ;
McCray, PB ;
Chang, SMW ;
Ulich, TR ;
Simonet, WS ;
Jolly, DJ ;
Davidson, BL .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2683-2687
[3]   Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver [J].
Bowling, WM ;
Kennedy, SC ;
Cai, SR ;
Duncan, JR ;
Gao, CH ;
Flye, MW ;
Ponder, KP .
HUMAN GENE THERAPY, 1996, 7 (17) :2113-2121
[4]   FACTORS INFLUENCING RETROVIRAL-MEDIATED GENE-TRANSFER INTO HEPATOCYTES IN-VIVO [J].
BRANCHEREAU, S ;
CALISE, D ;
FERRY, N .
HUMAN GENE THERAPY, 1994, 5 (07) :803-808
[5]   IN-SITU RETROVIRUS-MEDIATED GENE-TRANSFER INTO DOG LIVER [J].
CARDOSO, JE ;
BRANCHEREAU, S ;
JEYARAJ, PR ;
HOUSSIN, D ;
DANOS, O ;
HEARD, JM .
HUMAN GENE THERAPY, 1993, 4 (04) :411-418
[6]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436
[7]  
De Godoy JL, 1999, HUM GENE THER, V10, P249
[8]   Liver-directed gene transfer vectors [J].
Ferry, N ;
Heard, JM .
HUMAN GENE THERAPY, 1998, 9 (14) :1975-1981
[9]   RETROVIRAL-MEDIATED GENE-TRANSFER INTO HEPATOCYTES INVIVO [J].
FERRY, N ;
DUPLESSIS, O ;
HOUSSIN, D ;
DANOS, O ;
HEARD, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8377-8381
[10]  
GRISHAM JW, 1962, CANCER RES, V22, P842